Blood Plasma Derivatives Market By Type, Application and End-user - Global Industry Analysis & Forecast to 2027
Published On : October 2018 Pages : 180 Category: Medical Devices Report Code : HC101549
Blood Plasma Derivatives Market By Product (Factor VIII, Immunoglobulin, Albumin, Factor IX, Hyperimmune Globulin) Application (Hypogammaglobulinemia, von Willebrand's Disease (vWD), Hemophilia, Immunodeficiency Diseases, Other Application) End User (Clinics, Hospitals, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Blood Plasma Derivatives Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Blood plasma is clear fluid component of blood in which white blood cells, red blood cells, and platelets are suspended. It has an indispensable job in keeping up appropriate pH balance in the body and transporting supplements all through the body. It is made out of in excess of 100 unique proteins, including fibrinogen, albumin, protease inhibitors, immunoglobulins, and clotting variables. Plasma derivatives are items that are obtained from blood plasma on fractionation, and are broadly used to treat assortment of ailments.
Drivers and Restraints
The elements that drive the development of the blood plasma derivatives market incorporate increment in commonness of dangerous illnesses, for example, immunodeficiency issues and hemophilia, ascend in awareness towards blood and plasma donors, upsurge in aged populace, and development in reception of blood plasma derivatives products. Nonetheless, staggering expense of plasma subsidiary based treatment and danger of reactions related subsequent to utilizing plasma subordinates hinder the market development.
Regional Insights
Asia-Pacific is foreseen to rule the market over the analysis period, due to increasing population base, increase in disposable income, and enhancement in patient awareness about plasma derivatives.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- SK Plasma Co., Ltd.
- Biotest AG
- Baxter International Inc
- Octapharma AG
- Shire Plc
- Grifols, S.A
- Fusion Health Care Pvt. Ltd
- Green Cross Corporation
- LFB S.A
- CSL Limited
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Blood Plasma Derivatives Market, By Type, Estimates and Forecast, 2017-2027($Billion)
o Factor VIII
o Immunoglobulin
o Albumin
o Factor IX
o Hyperimmune Globulin
· Blood Plasma Derivatives Market, By Application, Estimates and Forecast, 2017-2027($Billion)
o Hypogammaglobulinemia
o von Willebrand's Disease (vWD)
o Hemophilia
o Immunodeficiency Diseases
o Other Application
· Blood Plasma Derivatives Market, By End User, Estimates and Forecast, 2017-2027($Billion)
o Hospitals
o Clinics
o Others
· Blood Plasma Derivatives Market, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Blood Plasma Derivatives Market, By Country
o U.S. Blood Plasma Derivatives Market
o Canada Blood Plasma Derivatives Market
o Mexico Blood Plasma Derivatives Market
o Europe
§ Europe Blood Plasma Derivatives Market, By Country
o Germany Blood Plasma Derivatives Market
o UK Blood Plasma Derivatives Market
o France Blood Plasma Derivatives Market
o Russia Blood Plasma Derivatives Market
o Italy Blood Plasma Derivatives Market
o Rest of Europe Blood Plasma Derivatives Market
o Asia-Pacific
§ Asia-Pacific Blood Plasma Derivatives Market, By Country
o China Blood Plasma Derivatives Market
o Japan Blood Plasma Derivatives Market
o South Korea Blood Plasma Derivatives Market
o India Blood Plasma Derivatives Market
o Southeast Asia Blood Plasma Derivatives Market
o Rest of Asia-Pacific Blood Plasma Derivatives Market
o South America
§ South America Blood Plasma Derivatives Market
o Brazil Blood Plasma Derivatives Market
o Argentina Blood Plasma Derivatives Market
o Columbia Blood Plasma Derivatives Market
o Rest of South America Blood Plasma Derivatives Market
o Middle East and Africa
§ Middle East and Africa Blood Plasma Derivatives Market
o Saudi Arabia Blood Plasma Derivatives Market
o UAE Blood Plasma Derivatives Market
o Egypt Blood Plasma Derivatives Market
o Nigeria Blood Plasma Derivatives Market
o South Africa Blood Plasma Derivatives Market
o Rest of MEA Blood Plasma Derivatives Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Blood Plasma Derivatives Market, By Type
5.1. Introduction
5.2. Global Blood Plasma Derivatives Revenue and Market Share by Type (2017-2027)
5.2.1. Global Blood Plasma Derivatives Revenue and Revenue Share by Type (2017-2027)
5.3. Factor VIII
5.3.1. Global Factor VIII Revenue and Growth Rate (2017-2027)
5.4. Immunoglobulin
5.4.1. Global Immunoglobulin Revenue and Growth Rate (2017-2027)
5.5. Albumin
5.5.1. Global Albumin Revenue and Growth Rate (2017-2027)
5.6. Factor IX
5.6.1. Global Factor IX Revenue and Growth Rate (2017-2027)
5.7. Hyperimmune Globulin
5.7.1. Global Hyperimmune Globulin Revenue and Growth Rate (2017-2027)
6. Blood Plasma Derivatives Market, By Application
6.1. Introduction
6.2. Global Blood Plasma Derivatives Revenue and Market Share by Application (2017-2027)
6.2.1. Global Blood Plasma Derivatives Revenue and Revenue Share by Application (2017-2027)
6.3. Hypogammaglobulinemia
6.3.1. Global Hypogammaglobulinemia Revenue and Growth Rate (2017-2027)
6.4. von Willebrand's Disease (vWD)
6.4.1. Global von Willebrand's Disease (vWD) Revenue and Growth Rate (2017-2027)
6.5. Hemophilia
6.5.1. Global Hemophilia Revenue and Growth Rate (2017-2027)
6.6. Immunodeficiency Diseases
6.6.1. Global Immunodeficiency Diseases Revenue and Growth Rate (2017-2027)
6.7. Other Application
6.7.1. Global Other Application Revenue and Growth Rate (2017-2027)
7. Blood Plasma Derivatives Market, By End User
7.1. Introduction
7.2. Global Blood Plasma Derivatives Revenue and Market Share by End User (2017-2027)
7.2.1. Global Blood Plasma Derivatives Revenue and Revenue Share by End User (2017-2027)
7.3. Clinics
7.3.1. Global Clinics Revenue and Growth Rate (2017-2027)
7.4. Hospitals
7.4.1. Global Hospitals Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Blood Plasma Derivatives Market, By Region
8.1. Introduction
8.2. Global Blood Plasma Derivatives Revenue and Market Share by Regions
8.2.1. Global Blood Plasma Derivatives Revenue by Regions (2017-2027)
8.3. North America Blood Plasma Derivatives by Countries
8.3.1. North America Blood Plasma Derivatives Revenue and Growth Rate (2017-2027)
8.3.2. North America Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Blood Plasma Derivatives by Countries
8.4.1. Europe Blood Plasma Derivatives Revenue and Growth Rate (2017-2027)
8.4.2. Europe Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Blood Plasma Derivatives by Countries
8.5.1. Asia-Pacific Blood Plasma Derivatives Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Blood Plasma Derivatives by Countries
8.6.1. South America Blood Plasma Derivatives Revenue and Growth Rate (2017-2027)
8.6.2. South America Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Blood Plasma Derivatives by Countries
8.7.1. Middle East and Africa Blood Plasma Derivatives Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. SK Plasma Co., Ltd.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Biotest AG
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Baxter International Inc
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Octapharma AG
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Shire Plc
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Grifols, S.A
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Fusion Health Care Pvt. Ltd
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Green Cross Corporation
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. LFB S.A
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. CSL Limited
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Blood Plasma Derivatives Market Competition, by Manufacturer
10.1. Global Blood Plasma Derivatives Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Blood Plasma Derivatives Price By Region (2017-2017)
10.3. Top 5 Blood Plasma Derivatives Manufacturer Market Share
10.4. Market Competition Trend
11. Blood Plasma Derivatives Market Forecast (2017-2027)
11.1. Global Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Blood Plasma Derivatives Market Forecast by Regions (2017-2027)
11.2.1. North America Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.1.1. United States Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.1.2. Canada Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.1.3. Mexico Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2. Europe Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2.1. Germany Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2.2. France Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2.3. UK Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2.4. Russia Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2.5. Italy Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3. Asia-Pacific Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3.1. China Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3.2. Japan Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3.3. Korea Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3.4. India Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.4. South America Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.4.1. Brazil Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.4.2. Argentina Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.4.3. Columbia Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.4.4. Rest of South America Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5. Middle East and Africa Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.3. Egypt Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.4. Nigeria Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.5. South Africa Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.6. Turkey Blood Plasma Derivatives Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Blood Plasma Derivatives Market Forecast (2017-2027)
11.3. Blood Plasma Derivatives Market Forecast by Type (2017-2027)
11.3.1. Blood Plasma Derivatives Forecast by Type (2017-2027)
11.3.2. Blood Plasma Derivatives Market Share Forecast by Type (2017-2027)
11.4. Blood Plasma Derivatives Market Forecast by Application (2017-2027)
11.4.1. Blood Plasma Derivatives Forecast by Application (2017-2027)
11.4.2. Blood Plasma Derivatives Market Share Forecast by Application (2017-2027)
11.5. Blood Plasma Derivatives Market Forecast by End User (2017-2027)
11.5.1. Blood Plasma Derivatives Forecast by End User (2017-2027)
11.5.2. Blood Plasma Derivatives Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Blood Plasma Derivatives Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Blood Plasma Derivatives Revenue and Revenue Share by Type (2017-2018)
Figure Global Factor VIII Revenue and Growth Rate (2017-2018)
Figure Global Immunoglobulin Revenue and Growth Rate (2017-2018)
Figure Global Albumin Revenue and Growth Rate (2017-2018)
Figure Global Factor IX Revenue and Growth Rate (2017-2018)
Figure Global Hyperimmune Globulin Revenue and Growth Rate (2017-2018)
Table Global Blood Plasma Derivatives Revenue and Revenue Share by Application (2017-2018)
Figure Global Hypogammaglobulinemia Revenue and Growth Rate (2017-2018)
Figure Global von Willebrand's Disease (vWD) Revenue and Growth Rate (2017-2018)
Figure Global Hemophilia Revenue and Growth Rate (2017-2018)
Figure Global Immunodeficiency Diseases Revenue and Growth Rate (2017-2018)
Figure Global Other Application Revenue and Growth Rate (2017-2018)
Table Global Blood Plasma Derivatives Revenue and Revenue Share by End User (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Blood Plasma Derivatives Revenue by Regions (2017-2018)
Figure North America Blood Plasma Derivatives Growth Rate (2017-2018)
Figure North America Blood Plasma Derivatives Revenue and Growth Rate (2017-2018)
Figure North America Blood Plasma Derivatives by Countries (2017-2018)
Figure North America Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2018)
Figure United States Blood Plasma Derivatives Growth Rate (2017-2018)
Figure United States Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Canada Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Mexico Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Europe Blood Plasma Derivatives Revenue and Growth Rate (2017-2018)
Figure Europe Blood Plasma Derivatives by Countries (2017-2018)
Figure Europe Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2018)
Figure Germany Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Germany Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Blood Plasma Derivatives Growth Rate (2017-2018)
Figure France Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Blood Plasma Derivatives Growth Rate (2017-2018)
Figure UK Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Russia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Italy Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Rest of Europe Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Asia-Pacific Blood Plasma Derivatives Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Blood Plasma Derivatives by Countries (2017-2018)
Figure Asia-Pacific Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2018)
Figure China Blood Plasma Derivatives Growth Rate (2017-2018)
Figure China Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Japan Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Korea Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Blood Plasma Derivatives Growth Rate (2017-2018)
Figure India Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Southeast Asia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Blood Plasma Derivatives Growth Rate (2017-2018)
Figure South America Blood Plasma Derivatives Revenue and Growth Rate (2017-2018)
Figure South America Blood Plasma Derivatives by Countries (2017-2018)
Figure South America Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Brazil Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Argentina Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Columbia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Rest of South America Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Middle East and Africa Blood Plasma Derivatives Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Blood Plasma Derivatives by Countries (2017-2018)
Figure Middle East and Africa Blood Plasma Derivatives Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Saudi Arabia Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Blood Plasma Derivatives Growth Rate (2017-2018)
Figure United Arab Emirates Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Egypt Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Nigeria Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Blood Plasma Derivatives Growth Rate (2017-2018)
Figure South Africa Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Turkey Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Blood Plasma Derivatives Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2017-2018)
Table SK Plasma Co., Ltd. Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biotest AG Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Baxter International Inc Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Octapharma AG Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Shire Plc Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Grifols, S.A Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Fusion Health Care Pvt. Ltd Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Green Cross Corporation Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table LFB S.A Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CSL Limited Blood Plasma Derivatives Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Blood Plasma Derivatives Market Share by Manufacturer
Figure Global Blood Plasma Derivatives Revenue and Market Share by Manufacturer
Table Global Blood Plasma Derivatives Price by Region (2017-2017)
Figure Top 5 Blood Plasma Derivatives Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Blood Plasma Derivatives Revenue (Millions USD) and Growth Rate (2018-2025)
Table Blood Plasma Derivatives Market Forecast by Regions (2018-2025)
Figure North America Blood Plasma Derivatives Market Forecast (2018-2025)
Figure United States Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Canada Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Mexico Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Europe Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Germany Blood Plasma Derivatives Market Forecast (2018-2025)
Figure France Blood Plasma Derivatives Market Forecast (2018-2025)
Figure UK Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Russia Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Italy Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Rest of Europe Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Asia-Pacific Blood Plasma Derivatives Market Forecast (2018-2025)
Figure China Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Japan Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Korea Blood Plasma Derivatives Market Forecast (2018-2025)
Figure India Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Southeast Asia Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Blood Plasma Derivatives Market Forecast (2018-2025)
Figure South America Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Brazil Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Argentina Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Columbia Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Rest of South America Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Middle East and Africa Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Saudi Arabia Blood Plasma Derivatives Market Forecast (2018-2025)
Figure United Arab Emirates Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Egypt Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Nigeria Blood Plasma Derivatives Market Forecast (2018-2025)
Figure South Africa Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Turkey Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Blood Plasma Derivatives Market Forecast (2018-2025)
Figure Global Blood Plasma Derivatives Forecast by Type (2018-2025)
Figure Global Blood Plasma Derivatives Market Share Forecast by Type (2018-2025)
Figure Global Blood Plasma Derivatives Forecast by Type (2018-2025)
Figure Global Blood Plasma Derivatives Forecast by Application (2018-2025)
Figure Global Blood Plasma Derivatives Market Share Forecast by Application (2018-2025)
Figure Global Blood Plasma Derivatives Forecast by Application (2018-2025)
Figure Global Blood Plasma Derivatives Forecast by End User (2018-2025)
Figure Global Blood Plasma Derivatives Market Share Forecast by End User (2018-2025)
Figure Global Blood Plasma Derivatives Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|